Latest round

Series B

Last raised

Oct 2024

Total raised

$33M

Investors

8

About Qnovia

Founded in 2018 and based in Virginia, US, Qnovia, Inc. operates as a pharmaceutical and platform MedTech company. In December 2024, Qnovia, Inc. The company’s product RespiRx™, a cartridge-based medical grade inhaled drug delivery system that offers nicotine replacement therapy (NRT) for smokers trying to quit smoking by delivering precise doses via inhalation while addressing cue-induced relapse behavior, under a 12-week step-down regimen. The company is working on the development of a universal API for inhaled drug delivery through an agnostic vibrating mesh nebulizer (VMN), in the areas of Smoking Cessation/NRT, Asthma, COPD, Oncology, Vaccine delivery, etc. The universal API technology also has a digital metered dose interface and Bluetooth-enabled mobile app functionality. The firm also plans to initiate a Phase 1 study for NRT in 2023 after the FDA approval.

Who invested in Qnovia

8 investors across 3 rounds

See all investors in Qnovia

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 29, 2024

    Amount

    $14M

    Investors

    Locked

  2. Series A

    Sep 28, 2022

    Amount

    $17M

    Investors

    Locked

  3. Seed

    Jan 10, 2020

    Amount

    $2.3M

    Investors

    Locked

Questions about Qnovia

Who invested in Qnovia?

Qnovia has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Qnovia raised?

Qnovia has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Qnovia last raise money?

Qnovia's most recent round on record is a Series B, in Oct 2024.

What does Qnovia do?

Founded in 2018 and based in Virginia, US, Qnovia, Inc.

Where is Qnovia headquartered?

Qnovia is headquartered in Richmond, US.

Which VCs invest in companies like Qnovia?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Qnovia's stage. Their profiles are linked below.

Raising like Qnovia? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.